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Background: Compared to other Australian women, Indigenous women are frequently at greater risk for
hypertensive disorders of pregnancy. We examined pre-pregnancy factors that may predict hypertension in
pregnancy in a cohort of Aboriginal and Torres Strait Islander women in north Queensland.
Methods: Data on a cohort of 1009 Indigenous women of childbearing age (15–44 years) who participated in a
1998–2000 health screening program in north Queensland were combined with 1998–2008 Queensland
hospitalisations data using probabilistic data linkage. Data on the women in the cohort who were hospitalised for
birth (n = 220) were further combined with Queensland perinatal data which identified those diagnosed with
hypertension in pregnancy.
Results: Of 220 women who gave birth, 22 had hypertension in the pregnancy after their health check. The mean
age of women with and without hypertension was similar (23.7 years and 23.9 years respectively) however
Aboriginal women were more affected compared to Torres Strait Islanders. Pre-pregnancy adiposity and elevated
blood pressure at the health screening program were predictors of a pregnancy affected by hypertension. After
adjusting for age and ethnicity, each 1 cm increase in waist circumference showed a 4% increased risk for
hypertension in pregnancy (PR 1.04; 95% CI; 1.02-1.06); each 1 point increase in BMI showed a 9% adjusted increase
in risk (1.09; 1.04-1.14). For each 1 mmHg increase in baseline systolic blood pressure there was an age and
ethnicity adjusted 6% increase in risk and each 1 mmHg increase in diastolic blood pressure showed a 7% increase
in risk (1.06; 1.03-1.09 and 1.07; 1.03-1.11 respectively). Among those free of diabetes at baseline, the presence of
the metabolic syndrome (International Diabetes Federation criteria) predicted over a three-fold increase in
age-ethnicity-adjusted risk (3.5; 1.50-8.17).
Conclusions: Pre-pregnancy adiposity and features of the metabolic syndrome among these young Aboriginal and
Torres Strait Islander women track strongly to increased risk of hypertension in pregnancy with associated risks to
the health of babies.
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Hypertensive disorders complicate 5-10% of pregnancies
and contribute greatly to maternal and fetal morbidity
and mortality throughout the world [1-3]. Population-
based Australian studies undertaken in Victoria [4] and
South Australia [5] have shown a prevalence of 9.8%
and 9.2% respectively, however, Australian Indigenous
women have been reported as having 66% greater risk
for pregnancy-induced hypertension when compared
with non-Indigenous women [6]. Australian Aboriginal
and Torres Strait Islander women are also at compara-
tively higher risk for developing chronic hypertension
and cardiovascular disease at a younger age than other
Australian women [7,8]. Poor cardiovascular health prior
to pregnancy modulates maternal preeclamptic syn-
drome so that frequency and severity of hypertensive
disease in pregnancy are increased [9]. Women with
chronic hypertension may have uneventful pregnancies
when their hypertension remains mild to moderate,
however, overall outcomes are poorer than for normo-
tensive women and they are at at greater risk of
developing preeclampsia (≥20%) [10]. Preeclampsia
occurs in about 3-5% of pregnancies [11] and is the
hypertensive condition whether it occurs alone or
superimposed on chronic hypertension most often
associated with maternal and fetal complications includ-
ing fatalities [1]. The disorder is an early marker not
only for future maternal cardiovascular and metabolic
disease, [1,11,12] but also confers long-term risk for car-
diovascular disease among infants [2]. Hypertension dur-
ing pregnancy has been identified as a predictor of poor
birth outcomes in Aboriginal and Torres Strait Islander
women in north Queensland [13]. However, it remains
unclear why this group of women have an increased risk
for hypertension in pregnancy.
Pre-pregnancy overweight and obesity have been
identified as risk factors for hypertensive disorders of
pregnancy [14,15]. In the United States, obesity is the
leading risk factor for preeclampsia; it confers a three-
fold increased risk and is present in 30% of cases [16].
Now a major epidemic in developed countries including
Australia, obesity is impacting on the health and well-
being of Indigenous Australians. With the change from
traditional carbohydrate based diets to energy dense
high fat diets, combined with lower levels of physical ac-
tivity [17], rates of obesity among Aboriginal and Torres
Strait Islander women of childbearing age have escalated
[18]. We examined pre-pregnancy factors that may
predict any hypertension in pregnancy in a cohort of
Aboriginal and Torres Strait Islander women in north
Queensland. We hypothesised that abnormal pre-
pregnancy blood pressure levels and maternal adipos-
ity would increase the risk of hypertensive disorders
during pregnancy.Methods
Study population
The Aboriginal and Torres Strait Islander women in this
study were participants in the March 1998-December
2000 Well Person’s Health Check (WPHC) cross-
sectional health survey [19], which included 26 rural and
remote Indigenous communities in the Bowen, Cairns,
Cape York, Torres Strait and Mount Isa Health service
districts. All adults were invited to participate through
printed media, local radio and word of mouth via the
local health service, community council and community
groups. The survey was attended by 2862 Indigenous
people aged 15 years and over, giving an overall partici-
pation rate of 44.5% (according to local census data)
[20]; 51.7% were female. Participants overall, were not dif-
ferent demographically from the age and sex distribution
of the Indigenous population who did not attend, based
on census data. A subset of women from the original sur-
vey data were selected for this study because the WPHC
occurred when they were aged between 15–44 years
(a generally accepted range of childbearing age).
Data sources
Three datasets were linked to bring together information
on maternal pre-pregnancy factors (anthropometric, bio-
chemical and lifestyle) gathered at the WPHC, and the
presence or absence of a hypertensive disorder during
the next pregnancy following this health check. First,
records of Aboriginal and Torres Strait Islander women
of childbearing age who attended the WPHC (details of
the survey are outlined below) were linked to Queens-
land hospital Unit Registration numbers by probabilistic
matching of name, date of birth and residential address.
The second dataset contained hospitalisations data (in-
cluding International Classification of Disease (ICD) 9
and ICD 10 codes and adjacent diagnosis-related groups
and descriptions) identified those women who were
hospitalised for pregnancy-related conditions after the
date of their WPHC up to the study censor date on 30
March 2008. To idenify women who had a hypertensive
disorder of pregnancy after the WPHC, a third dataset
provided by Statistical Output, Health Statistics Centre,
Queensland Health was added. The third dataset
included perinatal data specific to those women who
had been hospitalised for birth of an infant of at least
20 weeks completed gestation or a birthweight >400 g
when gestation was unknown [21]. When a woman was
hospitalised for more than one birth during the follow-
up period, only perinatal data for the birth nearest the
health check was requested. Women who were likely to
have been pregnant at the time of their health check
were excluded based on the date of their health check,
the date of their delivery and the estimated gestation of
the pregnancy at the time of birth.
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who had hypertensive conditions (ICD O10-O16) during
their pregnancy (Figure 1). The outcome measure
“hypertension in pregnancy” in this study applies to
women who were recorded in the perinatal dataset as re-
ceiving a diagnosis of one of the forms of the disorder;
pre-existing hypertension (ICD O10), pre-existing hyper-
tension with superimposed preeclampsia-eclampsia (ICD
O11), gestational hypertension without proteinuria (ICD
013) and preeclampsia-eclampsia (ICD O14 and O15).Well person’s health check
A standardised proforma was used for data collection in
the baseline WPHC survey. Body measurements and
specimen collection were performed by a multidisciplin-
ary team of trained staff from the Cairns Tropical Public
Health Unit (Queensland Health) and local health staff
in each communtiy. Face-to-face interviews followed a
structured questionnaire. Fasting venous blood samples
were collected by a medical officer, registered nurse or
trained phlebotomist [19].Anthropometric measures
Participants were invited to attend in the early morning
following at least an 8 h fast. They were weighed in light
clothing to the nearest 0.1 kg on digital electronic scales
and height was measured to the nearest centimetre.
Body mass index (BMI) was calculated as weight (kg)
divided by height squared (m2). Waist circumference
was measured to the nearest centimetre. Anthropomet-
ric cut-offs were set according to World Health Organ-
isation criteria [22].1998-
2000
Mar
2008
Well 
Person’s 
Health 
Check data
Hospital
data
Perinatal
data
No perinatal record 
n=10
Miscarriage or 
ectopic n=51
Outcome 
unknown n=2
Complete record
n=220
Women who 
gave birth
n=230
Pregnant at health 
check n=48
No pregnancy after 
health check n=678 Pregnancy after 
health check n=283
Not pregnant at 
health check n=961
Women who attended WPHC 1998-2000 who 
were of childbearing age (15-44 year) N=1009
No hypertension in 
pregnancy n=198
Hypertension in 
pregnancy n=22
Figure 1 Flow chart including datasets linked (right) and
timeline (far right).Blood pressure
Seated blood pressure was recorded three times over ap-
proximately 10 min with an automated blood pressure
monitor, and mean systolic and diastolic measurements
were calculated.
Self-reported behavioural factors
Fruit and vegetable intake was self-reported by 24-h re-
call and 7-day recall was used to assess the duration and
intensity of physical activity. The participants were
categorised as having adequate physical activity if they
reported a minimum of 30 min of moderate to vigorous
exercise on at least 5 days in the week. Current smoking
status was self-reported. Participants who drank alcohol
self-reported the types and amounts of alcohol consumed
in the week before the health check; they were then
categorised as being safe drinkers, non-drinkers or harm-
ful (“risky”) drinkers according to Australian National
Health and Medical Research Council guidelines (2001).
Risky drinking for women was defined as more than two
standard drinks per day or more than four on any single
occasion. The physical activity, smoking and alcohol
intake measures have been widely used [23] and the 24-h
recall dietary questionnaire and red cell folate measure
have been validated against other measures of micronu-
trient intake and the quality of the diet with respect to
fruit and vegetables [24,25].
Biochemical measures
Early-morning fasting venous blood samples were
collected in ethylenediamine tetra-acetic acid vacuum
tubes and clotted serum separator vacuum tubes (spun for
10 min at 1000 RCF in a swinging bucket centrifuge and
separated within 1 h). Samples were stored in 4-8C and
transported for analysis within 24 hours. The biochemical
measurements included glucose, triglycerides, total chol-
esterol, high density lipoprotein cholesterol, γ-glutamyl
transferase and red cell folate. Glucose and lipids were
measured using photometric enzyme endpoint assay with
Cobas Integra 700/400 (Roche Diagnostic, Switzerland).
γ -Glutamyl transferase was measured by a kinetic photo-
metric procedure with Cobas Integra 800 (Roche Diagnos-
tic, Switzerland). An elevated level was defined as ≥ 50 U/L
and < 50 U/L as normal, according to criteria established by
Queensland Health Pathology Service (http://www.health.
qld.gov.au/qhcss/qhps/default.asp). Red cell folate was
measured with the Bayer Advia Centaur automated im-
munoassay system (Bayer, Australia) by the Queensland
Health Pathology Service in Brisbane. The reference range
for this assay was 295–1800 nmol/L.
Urine specimens collected in sterile 50-ml containers
were either the first morning or at least 2 h after the
most recent void. If protein was detected by dipstick
urinalysis (Combur-test, Roche) or if the participant was
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>30 kg/m2), the albumin: creatinine ratio was measured by
immunoassay in grams per mole. Microalbuminuria was
defined as an albumin:creatinine ratio of 3.4-34 g/mol, and
macroalbuminuria as >34 g/mol [26]. From May 1999 to
the end of the project, the albumin:creatinine ratio was
measured in all urine specimens.Metabolic syndrome
The metabolic syndrome in this study is defined according
to the International Diabetes Federation criteria as com-
prising waist circumference ≥ 80 cm plus two or more of
the following: raised triglycerides (≥ 1.7 mmol/L), reduced
high-density lipoprotein (< 1.29 mmol/L), raised blood
pressure (systolic ≥ 130 mm Hg or diastolic ≥ 85 mm Hg)
and raised plasma glucose (≥ 5.6 mmol/L) (http://www.idf.
org/metabolic-syndrome).Ethics
Ethics approval for the WPHC was provided by the
Cairns Base Hospital Ethics Committee in March 1998.
The participants provided consent to have their
Queensland Health medical records reviewed and
linked to their WPHC records. The current data linkage
study was approved by the University of South Australia
and Cairns Base Hospital Human Research Ethics
Committees (June 2009 and September 2009) with sup-
port from the peak health councils representing Indi-
genous people in the region: Apunipima and the Torres
Strait Islander and Northern Peninsula Area Health
Councils.Statistical analysis
The data were analysed in a generalised linear model
(Poisson distribution) with robust variance estimates to
calculate prevalence ratios (PRs) and 95% confidence
intervals (CIs) with 2 sided p-values of 0.05 for baseline
characteristics associated with hypertension during the
first pregnancy after their health check. Data are
presented in both unadjusted and adjusted analyses. An
a priori decision was taken to adjust the model for age
because hypertension is commonly associated with in-
creasing age and, because it was expected that Aborigi-
nal and Torres Strait Islander women would differ in
their anthropometic and metabolic characteristics, ethni-
city was included in the adjusted model. Further adjust-
ment for months from participation in the baseline
survey to time of admission for birth was not associated
with the outcome and was not retained. Fruit and vege-
table intake was excluded from the analyses due to very
small cell sizes. The analysis was conducted with STATA
11 (STATAcorp, College Station, Texas, USA).Results
Pre-pregnancy characteristics at the baseline health check
At the baseline WHPC, there were 1009 women of child-
bearing age (15–44 years) in the study sample. We
excluded 48 women because they were pregnant at the time
of their health check. Of the remaining 961 women, 61.2%
identified as Aboriginal, 30.7% as Torres Strait Islander,
and 8.1% identified as both Torres Strait Islander and
Aboriginal. Characteristics of the cohort (demographics,
waist circumferences BMIs, smoking status, alcohol use,
fruit and vegetable intake, physical activity, blood pressure,
blood lipids, red cell folate, fasting glucose, kidney and
liver function tests, prevalences of metabolic syndrome
and diabetes) are reported in detail elsewhere [20]. Ab-
dominal obesity (waist circumference ≥ 88 cm) was found
in 60.5% of women, and 37.1% had a BMI > 30. Adequate
fruit and vegetable intake and physical activity were low
(1.5 and 21% respectively), and self-reported rates of
tobacco smoking and risky drinking in the week before
the baseline health check were high (60.8% and 41.9%,
respectively).
Prevalence of hypertension in pregnancy
Figure 1 shows that 283 women were hospitalised for a
pregnancy-related condition in the time between their
WPHC in 1998–2000 and March 2008; 51 pregnancies
ended in miscarriage or because of an ectopic preg-
nancy, and two pregnancy outcomes were unknown. In
the time up to the censor date, 230 women were
hospitalised for birth. Ten of these women were
excluded because perinatal records were not matched.
Of the remaining 220 women (21.4% were primiparous),
9 had pre-existing hypertension at the time of their
WPHC. Seven women with normal blood pressure at
baseline developed gestational hypertension (new-onset
hypertension after mid-pregnancy, in the absence of pro-
teinuria). Seven women (3.2%) developed preeclampsia
(hypertension and proteinuria); six cases were in women
with normal baseline blood pressure and were described
as moderate, and one severe case was superimposed on
pre-existing hypertension. Overall, 22 women (10%) had
a hypertensive disorder in their first pregnancy following
the baseline WPHC.
Pre-pregnancy characteristics as risk for hypertension in
pregnancy: unadjusted analyses
Unadjusted analysis in Table 1 shows that of the 22
women who had hypertension in the first pregnancy
after their health check, 72.7% were Aboriginal; the
remaining 27.3% of the women identified as Torres
Strait Islander or, both Torres Strait Islander and Abori-
ginal (p =0.157). There was no difference in mean age
between the women who did and did not have hyperten-
sion in pregnancy (p =0.914). Elevated pre-pregnancy
Table 1 Baseline characteristics of the cohort, by hypertension in pregnancy (n = 220)
Pre-pregnancy characteristic No hypertension during pregnancy
(n = 198)
Hypertension during pregnancy
(n = 22)
n % of n or mean (sd) n % of n or mean (sd) Unadjusted PR (95% CI) p value
Indigenous group
Aboriginal 112 56.6 16 72.7 1.00
Torres Strait Islandera 86 43.4 6 27.3 0.52 (0.21-1.28) 0.157
Age years (mean, sd) 198 23.9 (5.4) 22 23.7 (6) 0.99 (0.92-1.07) 0.914
Waist circumference (cm)
< 80 65 33 5 22.7 1.00
80-87.9 40 20.3 2 9.1 0.67 (0.13-3.30) 0.619
≥ 88 92 46.7 15 68.2 1.96 (0.74-5.17) 0.372
Waist circumference (mean, sd) 197 88.7 (15.8) 22 95.4 (17.6) 1.02 (1.00-1.04) 0.054
BMI category (kg/m2)
< 18.5 23 11.6 0 0
18.5-25 74 37.4 7 31.8 1.00
25-30 48 24.2 6 27.3 1.29 (0.46-3.63) 0.635
≥ 30+ 53 26.7 9 40.9 1.68 (0.66-4.26) 0.276
BMI (mean, sd) 198 26.1(7) 22 29 (6.5) 1.05 (1.00-1.09) 0.033
Smoker
No 57 28.9 8 36.4 1.00
Yes 140 71.1 14 63.6 0.74 (0.33-3.68) 0.469
Alcohol use
Safe drinker 56 28.9 4 18.2 1.00
Non drinker 64 33 7 31.8 1.48 (0.45-4.82) 0.517
Risky drinker 74 38.1 11 50 1.94 (0.65-5.82) 0.236
Enough physical activity
No 160 80.8 17 77.3 1.00
Yes 38 19.2 5 22.7 1.23 (0.47-3.11) 0.691
Systolic blood pressure (mmHg)
≤ 120 142 72.1 8 36.4 1.00
> 120 55 27.9 14 63.6 3.80 (1.67-8.67) 0.001
Diastolic blood pressure (mmHg)
≤ 80 190 96.5 19 86.4 1.00
> 80 7 3.5 3 13.6 3.30 (1.16-9.35) 0.025
Cholesterol (mg/dL)
≤ 5.5 176 90.3 20 90.9 1.00
> 5.5 (elevated) 19 9.7 2 9.1 0.93 (0.23-3.73) 0.922
Triglycerides (mmol/L)
≤ 2 173 89.6 19 86.4 1.00
> 2 (elevated) 20 10.4 3 13.6 1.31 (0.42-4.12) 0.635
HDL cholesterol (mmol/L)
> 1 108 56.5 9 40.9 1.00
≤ 1 (low) 83 43.5 13 59.1 1.76 (0.78-3.95) 0.170
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Table 1 Baseline characteristics of the cohort, by hypertension in pregnancy (n = 220) (Continued)
Red cell folate (nmol/L)
≥ 295 126 65 17 77.3 1.00
< 295 (low) 68 35 5 22.7 0.58 (0.22-1.50) 0.260
Fasting glucose (mmol/L)
≤ 5.5 182 93.3 20 90.9 1.00
> 5.5 13 6.7 2 9.1 1.35 (0.35-5.24) 0.668
Albumin:creatinine ratio (mg/mmol)
≤ 3.4 121 82.3 13 68.4 1.00
>3.4 26 17.7 6 31.6 2.25 (0.39-13.05) 0.366
Gamma-glutamyl transferase (U/L)
≤ 50 183 93.9 20 90.9 1.00
> 50 (elevated) 12 6.1 2 9.1 1.45 (0.37-5.60) 0.590
Metabolic syndromeb
No 153 80.1 12 57.1 1.00
Yes 38 19.9 9 42.9 2.63 (1.18-5.88) 0.018
Denominators vary because of missing values.
aWomen in this group self-identified as Torres Strait Islander or, as both Torres Strait Islander and Aboriginal origin.
bDefined by International Diabetes Federation criteria as comprising waist circumference ≥ 80 cm plus two or more of the following: raised triglycerides (≥
1.7 mmol/L), reduced high-density lipoprotein (< 1.29 mmol/L), raised blood pressure (systolic ≥ 130 mm Hg or diastolic ≥ 85 mm Hg) and raised plasma glucose
(≥ 5.6 mmol/L). Women with diabetes excluded.
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predicted more than a three-fold risk for hypertension in
pregnancy (p = 0.001 and 0.025 respectively). The affected
women were more likely to have a higher mean waist cir-
cumference (p =0.054) and a mean BMI three points
above the women with no hypertension (p = 0.033). More
women who had hypertension reported risky drinking
(50% versus 38%; p =0.236) and elevated albumin:creatin-
ine ratio and low levels of high density lipoprotein choles-
terol were more common (31.6% versus 17.7% and 59.1%
versus 43.5% respectively) though not statistically signifi-
cant (p =0.366 and 0.170 respectively). Non-diabetic
women who were diagnosed with hypertension in their
pregnancy had more than twice the prevalence of features
of the metabolic syndrome at the baseline health check
(42.9% versus 19.9%; p = 0.018). Among all the women who
had a baby (n = 220), baseline self-reported levels of ad-
equate physical activity were low (19.5%) and smoking rates
and risky drinking were high (70% and 38.6% respectively).
Pre-pregnancy characteristics as risk for hypertension in
pregnancy: analysis adjusted for age and ethinicity
In a multivariable analysis (Table 2), a strong predictor for
having hypertension in pregnancy was elevated baseline
blood pressure. For each 1 mmHg increase in pre-
pregnancy systolic blood pressure there was an age and
ethnicity adjusted 6% increase in risk of hypertension in
pregnancy (PR 1.06; 1.03-1.09) and for each 1 mmHg in-
crease in diastolic blood pressure there was a 7% increase
in risk (1.07; 95% CI 1.03-1.11). Body fat was also animportant risk factor and for each 1 cm increase in waist
circumference there was a 4% age and ethnicity adjusted
increase in risk of hypertension in pregnancy (1.04;1.02-
1.06) and for each 1 point increase in BMI, there was a 9%
increase in risk (1.09; 1.04-1.14). The presence of meta-
bolic syndrome at baseline predicted over a three-fold in-
crease in adjusted risk among women free of diabetes at
baseline (3.5; 1.50-8.17). For each 1 mg/mmol increase in
pre-pregnancy albumin:creatine ratio there was an age
and ethnicity adjusted 1% increased risk (1.01; 1.00-1.02).
Pre-pregnancy alcohol use was not significantly associated
with hypertension in pregnancy however, for each 1 U/L
increase in γ-glutamyl transferase, possibly related to non-
alcoholic fatty liver disease, there was a 1% increase in
adjusted risk (1.01: 1.00-1.02). Pre-pregnancy smoking,
physical activity, fasting glucose, red cell folate and blood
fats were not statistically significantly associated with
hypertension in pregnancy in this study.
Discussion
Twenty-two of the 220 women who gave birth in the
8–10 years after their health check had hypertension
during their pregnancy. Seven of these women (3.2%) were
diagnosed with moderate (n = 6) or severe (n = 1)
preeclampsia, a rate equivalent to that found among other
population groups [11]. The strongest pre-pregnancy
predictors of hypertension during pregnancy in this co-
hort of Aboriginal and Torres Strait Islander women were
central adiposity (assessed by waist circumference), obesity
(assessed by BMI) and an elevated blood pressure
Table 2 Multivariable analysis for effects of pre-pregnancy factors and hypertension during pregnancy (n = 220)
Pre-pregnancy
characteristic
Unit increase Crude PR
(95% confidence interval)
p value PR adjusted for age and ethnicity
(95% confidence interval)
p value
Indigenous group
Aboriginal - 1.00
Torres Strait Islandera - 0.52 (0.21-1.28) 0.16
Age “1 year” 1.00 (0.92-1.07) 0.91
Waist circumference “1 cm” 1.02 (1.00-1.04) 0.05 1.04 (1.02-1.06) 0.001
BMI (kg/m2) “1 unit” 1.05 (1.00-1.09) 0.03 1.09 (1.04-1.14) <0.001
Alcohol intake
Safe drinker - 1.00 1.00
Non drinker - 1.47 (0.45-4.82) 0.52 1.38 (0.43-4.47) 0.59
Risky drinker - 1.94 (0.64-5.91) 0.24 1.79 (0.58-5.49) 0.31
Non-smoker Smoker 0.74 (0.33-1.68) 0.47 0.68 (0.30-1.55) 0.36
Enough physical activity < 30 min/day 5 days per week 0.83 (0.32-2.12) 0.69 0.78 (0.31-1.55) 0.60
Systolic blood pressure “1 mmHg” 1.05 (1.02-1.07) <0.001 1.06 (1.03-1.09) <0.001
Diastolic blood pressure “1 mmHg” 1.06 (1.03-1.10) <0.001 1.07 (1.03-1.11) <0.001
Cholesterol “1 mmol/L” 1.27 (0.88-1.83) 0.21 1.38 (0.93-2.06) 0.10
Triglycerides “1 mmol/L” 1.18 (0.96-1.46) 0.12 1.17 (0.92-1.49) 0.20
HDL cholesterol (≤ 1 = low) “1 mmol/L” 0.74 (0.13-4.22) 0.73 0.61 (0.09-3.82) 0.60
Red cell folate “1 nmol/L” 1.00 (1.00-1.01) 0.006 1.00 (1.00-1.01) 0.009
Fasting glucose “1 mmol/L” 1.06 (0.82-1.37) 0.67 1.14 (0.87-1.50) 0.33
Albumin:creatinine ratio “1 mg/mmol” 1.01 (1.00-1.02) 0.02 1.01 (1.00-1.02) 0.003
Gamma-glutamyl transferase “1 U/L” 1.01 (1.00-1.02) 0.02 1.01 (1.00-1.02) 0.003
Hyper-triglyceridemic waistb - No Yes 1.55 (0.40-5.93) 0.53 1.53 (0.39-6.01) 0.54
Metabolic syndromec - No Yes 2.63 (1.18-5.88) 0.02 3.50 (1.50-8.17) 0.004
Denominators vary because of missing values.
aWomen in this group self-identified as Torres Strait Islander or, as both Torres Strait Islander and Aboriginal origin.
bDefined as raised triglycerides (> 2 mmol/l and waist circumference ≥ 88 cm).
cDefined by International Diabetes Federation criteria as comprising waist circumference.
≥ 80 cm plus two or more of the following: raised triglycerides (≥ 1.17 mmol/l), reduced high-density lipoprotein (< 1.29 mmol/L), raised blood pressure
(systolic ≥ 130 mmHg or diastolic ≥ 85 mmHg) and raised plasma glucose (≥ 5.6 mmol/L). Women with diabetes excluded.
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ing a sample of the Indigenous populations of Australia,
which have some of the highest prevalence of hypertensive
pregnancy, we have emphasised pre-pregnancy obesity
and hypertension as independent contributors to this dis-
ease. Both of these risk factors are potentially amenable to
intervention before pregnancy.
Our results add to previous Australian research that has
identified elevated pre-pregnancy BMI as an important fac-
tor in the development of serious hypertensive disorders of
pregnancy [27]. A systematic review of international con-
trolled studies of risk factors for preeclampsia at antenatal
booking showed that raised BMI before pregnancy (relative
risk 2.47; 1.66-3.67) is one of the few amenable to interven-
tion [28]. Other factors known to increase risk that cannot
be altered prior to pregnancy include previous history or
family history of preeclampsia, multiple pregnancy,
nulliparity, and maternal age among multiparous women.
Our study highlights the need to focus health promotionefforts on encouraging healthy body weight among Aborigi-
nal and Torres Strait Islander women of childbearing age.
Elevated pre-pregnancy blood pressure in this study
was an additional predictor of a hypertensive disorder of
pregnancy. Hypertension among Indigenous women and
men aged 25–50 years has previously been shown to be
highly prevalent in communities included in the study
[12]. Pre-pregnancy blood pressure assessment in this
high risk population is important because undiagnosed
chronic hypertension can be masked in early pregnancy
due to physiological changes that may cause initial
decreases in blood pressure, then misdiagnosed later in
the pregnancy as a gestational disorder when abnormal
readings re-surface [1]. One of the best predictors of
chronic hypertension for Aboriginal and Torres Strait Is-
lander Australians is overweight and obesity established
by elevated waist circumference [17].
Aside from pre-pregnancy adiposity and raised blood
pressure, two additional risk factors associated with poor
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γ -glutamyl transferase, increased the risk for hypertension
during pregnancy among the cohort. Raised albumin:cre-
atine ratio as a marker of kidney damage and raised
γ -glytamyl transferase as a marker of non-alcoholic fatty
liver disease or risky alcohol use, provide a general picture of
poor health in women of childbearing age. Among women
in the cohort free of diabetes at baseline, presence of meta-
bolic syndrome as defined by the International Diabetes
Federation criteria, showed over a three-fold risk for hyper-
tension during pregnancy. From a population health per-
spective, health risks among this cohort are exacerbated by
high rates of smoking and risky alcohol use and low levels of
physical activity. The extent of health challenges faced by
these young women, and our improved understanding of
how ‘fetal programming’ predicts the immediate and long
term health of the next generation, call for interventions well
before pregnancy begins in this population.
Encouraging weight loss during pregnancy is not a suitable
strategy; weight loss outside of pregnancy requires lowering
caloric intake or raising energy expended. Programs that in-
corporate a combination of physical activity and nutrition
education have been shown to reduce body weight [29] and
blood pressure [30,31]. In this study, less than 20% of the
women reported undertaking adequate physical activity in
the week before their baseline health check. It has been
shown that when women exercise between 3 months and
1 year before or during pregnancy, the risk of preeclampsia
is reduced [32,33]. The benefits of exercise prior to preg-
nancy for reducing the risk of preeclampsia, suggest that
weight reduction interventions should feature well-designed
physical activity components that focus on fitness, nutrition
and weight loss in preference to weight loss alone.
This study is limited by its small sample size and low
participation rate of eligible women (<50%) in the baseline
survey and there is a possible downward and upward re-
sponse bias to self-reported variables including current
smoking status, alcohol use, fruit and vegetable intake and
levels of physical activity. Despite the low participation
rate, the cohort was well characterised at baseline with
standardised body and biochemical measurements and
the internal validity of the associations found between
baseline risk and later hypertension in pregnancy should
be high. A potential limitation of the study is the ability of
perinatal data collections to report maternal health
indicators accurately. A Canadian validation study found
that gestational hypertensive disorders were more accur-
ately coded (sensitivity 88%) than other variables, for ex-
ample fetal/birth asphyxia (sensitivity 14.3%) [34]. The
study is further limited by lack of data regarding whether or
not women had a hypertensive disorder during a previous
pregnancy as risk factors for recurrence are likely to be dif-
ferent for those women whose pregnancy is affected for the
first time. The use of measured, rather than self-reported,anthropometric variables is an advantage in the study par-
ticularly because of the importance of body mass and cen-
tral adiposity in predicting hypertension in pregnancy.
Conclusions
Our study findings have enhanced our knowledge base, in
general, about risk for hypertension in pregnancy. These
data demonstrate high levels of obesity and poor metabolic
health among Aboriginal and Torres Strait Islander women
of child-bearing age in north Queensland that increase the
risk for hypertensive disorders of pregnancy. Levels of phys-
ical activity were low. The study was undertaken in remote
communities situated in isolated areas of Cape York and on
Torres Strait Islands that frequently have limited resources
for access to secure supplies of healthy foods and safe exer-
cise environments. As well as improving food supply, con-
sideration should be given to improving community
infrastructures to include identified facilities (gymnasiums,
walking paths and improved night lighting) which provide
physical activity programs aimed at improving the health of
young women prior to their first pregnancy and between
pregnancies. Beneficial effects of better metabolic health of a
woman of childbearing age may also have a strong positive
effect on the health of her children across their lifespan.
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